339 related articles for article (PubMed ID: 11748642)
1. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
Meije CB; Hakvoort TB; Swart GW; Westerhof W; Lamers WH; Das PK
J Pathol; 2002 Jan; 196(1):51-8. PubMed ID: 11748642
[TBL] [Abstract][Full Text] [Related]
2. Multiple complementary transcripts of pCMa1, a novel gene located at chromosome 11p15.1-2, and melanocytic cell transformation.
Meije CB; Das PK; Jans MM; Hau C; van der Wal AC; Alders M; Hakvoort TB; Weidle UH; Lamers WH; Swart GW
J Pathol; 2002 Aug; 197(5):668-76. PubMed ID: 12210088
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
Petersson S; Shubbar E; Enerbäck L; Enerbäck C
Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
[TBL] [Abstract][Full Text] [Related]
4. Micro-anatomy related antigen expression in melanocytic lesions.
Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
[TBL] [Abstract][Full Text] [Related]
5. Identification of differentially expressed messenger RNAs in human melanocytes and melanoma cells.
Simon HG; Risse B; Jost M; Oppenheimer S; Kari C; Rodeck U
Cancer Res; 1996 Jul; 56(13):3112-7. PubMed ID: 8674069
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
7. Specifically regulated genes in malignant melanoma tissues identified by subtractive hybridization.
Hipfel R; Schittek B; Bodingbauer Y; Garbe C
Br J Cancer; 2000 Mar; 82(6):1149-57. PubMed ID: 10735498
[TBL] [Abstract][Full Text] [Related]
8. Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and metastatic melanomas.
Gong J; Chen N; Zhou Q; Yang B; Wang Y; Wang X
J Clin Pathol; 2005 Oct; 58(10):1081-5. PubMed ID: 16189155
[TBL] [Abstract][Full Text] [Related]
9. In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers.
Bosserhoff AK; Moser M; Hein R; Landthaler M; Buettner R
J Pathol; 1999 Mar; 187(4):446-54. PubMed ID: 10398105
[TBL] [Abstract][Full Text] [Related]
10. Identification and functional characterization of ASK/Dbf4, a novel cell survival gene in cutaneous melanoma with prognostic relevance.
Nambiar S; Mirmohammadsadegh A; Hassan M; Mota R; Marini A; Alaoui A; Tannapfel A; Hegemann JH; Hengge UR
Carcinogenesis; 2007 Dec; 28(12):2501-10. PubMed ID: 17768177
[TBL] [Abstract][Full Text] [Related]
11. Patterns of melastatin mRNA expression in melanocytic tumors.
Deeds J; Cronin F; Duncan LM
Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
[TBL] [Abstract][Full Text] [Related]
12. Detection of the c-met proto-oncogene product in normal skin and tumours of melanocytic origin.
Saitoh K; Takahashi H; Sawada N; Parsons PG
J Pathol; 1994 Nov; 174(3):191-9. PubMed ID: 7823252
[TBL] [Abstract][Full Text] [Related]
13. Tumor progression in the human melanocytic system.
Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment.
Seftor EA; Brown KM; Chin L; Kirschmann DA; Wheaton WW; Protopopov A; Feng B; Balagurunathan Y; Trent JM; Nickoloff BJ; Seftor RE; Hendrix MJ
Cancer Res; 2005 Nov; 65(22):10164-9. PubMed ID: 16288000
[TBL] [Abstract][Full Text] [Related]
15. Signatures of microRNAs and selected microRNA target genes in human melanoma.
Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of microtubule-associated protein 2 in melanocytic skin lesions.
Gambichler T; Rotterdam S; Radkowski K; Altmeyer P; Kreuter A
Am J Clin Pathol; 2009 May; 131(5):710-4. PubMed ID: 19369632
[TBL] [Abstract][Full Text] [Related]
17. Selective expression of Syntaxin-7 protein in benign melanocytes and malignant melanoma.
Strömberg S; Agnarsdóttir M; Magnusson K; Rexhepaj E; Bolander A; Lundberg E; Asplund A; Ryan D; Rafferty M; Gallagher WM; Uhlen M; Bergqvist M; Ponten F
J Proteome Res; 2009 Apr; 8(4):1639-46. PubMed ID: 19714869
[TBL] [Abstract][Full Text] [Related]
18. Induction of growth factor RNA expression in human malignant melanoma: markers of transformation.
Albino AP; Davis BM; Nanus DM
Cancer Res; 1991 Sep; 51(18):4815-20. PubMed ID: 1716514
[TBL] [Abstract][Full Text] [Related]
19. Identification and cloning of genes displaying elevated expression as a consequence of metastatic progression in human melanoma cells by rapid subtraction hybridization.
Boukerche H; Su ZZ; Kang DC; Fisher PB
Gene; 2004 Dec; 343(1):191-201. PubMed ID: 15563845
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of melanocytes following Q-Switched Ruby laser irradiation.
Hafner C; Stempfl T; Bäumler W; Hohenleutner U; Landthaler M; Vogt T
Dermatology; 2008; 216(1):6-13. PubMed ID: 18032893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
